COSCIENS Biopharma Inc.
CSCIF
$2.09
-$0.16-7.27%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -55.43% | -57.38% | -66.43% | -53.43% | 145.48% |
| Total Receivables | -48.97% | -20.35% | 105.39% | 503.57% | 752.07% |
| Inventory | -51.43% | -46.79% | -40.39% | 3,735.94% | -32.88% |
| Prepaid Expenses | 75.94% | -29.20% | 47,625.00% | 11.27% | 1,998.77% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -64.33% | -40.44% | -33.64% | -- | 247.37% |
| Total Current Assets | -52.05% | -50.98% | -50.30% | -34.75% | 112.84% |
|
|
|||||
| Total Current Assets | -52.05% | -50.98% | -50.30% | -34.75% | 112.84% |
| Net Property, Plant & Equipment | -10.58% | -16.22% | -5.01% | 3,833.21% | -5.83% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.63% | -93.17% | -93.41% | -60.74% | -85.11% |
| Total Assets | -38.89% | -45.49% | -44.93% | -2.05% | 47.69% |
|
|
|||||
| Total Accounts Payable | -69.05% | -57.01% | -57.18% | 18.90% | 756.58% |
| Total Accrued Expenses | -52.00% | -63.95% | -32.00% | -0.52% | 224.35% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -20.66% | -47.65% | -48.65% | 64.29% | -9.36% |
| Total Finance Division Other Current Liabilities | 126.09% | -35.21% | -36.99% | 161.43% | -- |
| Total Other Current Liabilities | 126.09% | -35.21% | -36.99% | 161.43% | -- |
| Total Current Liabilities | -49.97% | -51.23% | -43.65% | 34.41% | 450.88% |
|
|
|||||
| Total Current Liabilities | -49.97% | -51.23% | -43.65% | 34.41% | 450.88% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.15% | 61.77% | 60.08% | 2,366.25% | 45.75% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -4.79% | -10.71% | 1.53% | -11.30% | -- |
| Total Liabilities | -19.72% | -20.95% | -14.09% | 11.56% | 708.45% |
|
|
|||||
| Common Stock & APIC | 0.61% | 1.05% | 2.72% | -92.33% | 66.35% |
| Retained Earnings | -69.35% | -269.29% | -1,223.74% | 96.09% | -378.01% |
| Treasury Stock & Other | -38.03% | -45.91% | -35.96% | -97.58% | -11.92% |
| Total Common Equity | -70.81% | -74.62% | -72.94% | -21.79% | -37.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -70.81% | -74.62% | -72.94% | -21.79% | -37.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -70.81% | -74.62% | -72.94% | -21.79% | -37.43% |
|
|
|||||